Fluence Therapeutics

Fluence Therapeutics is a spinoff of University Hospitals Case Medical Center commercializing photodynamic therapy for the treatment of psoriasis and other skin diseases.  Researchers at University Hospitals Case Medical Center and Case Western Reserve University have over many years developed, patented and conducted Phase I clinical trials on a photosensitizer known as Pc 4.  Pc 4 is a silicon phthalocyanine which, when excited by visible light, attacks tumor cells, abnormal vasculature, and other lipophilic sites and has a number of advantages over other photosensitizers.